Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Nordicus Partners Corporation (NORD)

Corbus Pharmaceuticals Holdings, Inc. and Nordicus Partners Corporation are both Biotechnology companies. Nordicus Partners Corporation is the larger, with a market value of $63.2M against $55.3M — 1.1× the size. Nordicus Partners Corporation grew revenue faster over the last twelve months: −71.7% against −73.7%. Across the 14 metrics below, Nordicus Partners Corporation leads on 8 and Corbus Pharmaceuticals Holdings, Inc. on 6.

Valuation

Metric CRBP NORD Biotechnology median
P/E n/m n/m 10.26
P/S 36.05 81.31 9.18
P/B 0.54 1.06 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.37 n/m 0.65
EV/Sales (26.17) 83.80 8.98
Earnings yield (216.43%) (8.24%) (34.89%)
Free cash flow yield (156.18%) (6.25%) (24.52%)

Profitability

Metric CRBP NORD Biotechnology median
Gross margin 0.00% 70.18% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (95.58%) (8.06%) (50.12%)
Return on assets (80.85%) (6.80%) (45.60%)
Return on invested capital 0.00% (4.43%) 0.00%

Growth

Metric CRBP NORD Biotechnology median
Revenue growth (TTM) (73.69%) (71.68%) 6.26%
EPS growth (last fiscal year) (60.33%) 30.58% 29.88%
Revenue growth, 5-year CAGR (14.34%) (71.31%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBP NORD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.71 0.18 4.89
Net debt to EBITDA 1.90 0.00 1.01

Dividend

Metric CRBP NORD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRBP NORD Biotechnology median
Market cap 55.32m 63.19m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack